Profile picture

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))
Membership: FESC Member
Follow
Biography
J. Wouter Jukema, MD, PhD, is professor and Head of Cardiology at Leiden University Medical Center (LUMC) in the Netherlands. He is also founding director of the Durrer Center for Cardiogenetic Research/NLHI Data- and Biobank in Amsterdam and co-chair of the Netherlands Heart Institute, as well as past Established Clinical Investigator of the Netherlands Heart Foundation His current interests, which comprise the majority of topics for his more than 1000 peer reviewed publications (with many in top journals like NEJM, Lancet, Science, Nature, Circulation, JACC and EHJ) focus on the field of athero-thrombosis and include interventional cardiology as well as atherosclerosis research (vascular biology, lipid modification, diabetes, anti-thrombotics/anti-platelets and genetics) in humans as well as in transgenic animals. Prof. Jukema has been leading and is princ. investigator in several large interventional/athero-thrombosis studies, a member/chair of various (inter)national /EU boards
Logo ESC

Contributor content

Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?
Session
Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?
27 August 2023
Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers
Session
Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers
26 August 2022
Lipid lowering beyond LDL-cholesterol and statins
Session
Lipid lowering beyond LDL-cholesterol and statins
28 August 2021
Managing patients with dyslipidaemia: how to tackle clinical inertia
Session
Managing patients with dyslipidaemia: how to tackle clinical inertia
30 August 2020
Coronary artery disease and comorbidities
Session
Coronary artery disease and comorbidities
1 September 2019
Evolving scientific evidence with PCSK9 inhibitors based on ODYSSEY outcomes
Session
Evolving scientific evidence with PCSK9 inhibitors based on ODYSSEY outcomes
1 September 2019
High sensitivity troponins in patients with suspected acute coronary syndromes
Session
High sensitivity troponins in patients with suspected acute coronary syndromes
31 August 2019
Lipids in atherosclerosis - Evolving concepts
Session
Lipids in atherosclerosis - Evolving concepts
27 August 2017
Copycat coronary killers
Session
Copycat coronary killers
30 August 2016
ACS management 2014: a case based approach according to new guidelines and registries
Session
ACS management 2014: a case based approach according to new guidelines and registries
2 September 2014

ESC 365 is supported by